The Peripheral Intravascular Ultrasound (IVUS) Catheter industry trends over the past 18 months reflect a dynamic landscape shaped by innovation and strategic collaborations. Key players have intensified partnerships, such as Boston Scientificโs 2023 alliance with a leading AI diagnostics firm to enhance real-time imaging analytics for peripheral vascular procedures. Meanwhile, mergers and acquisitions have accelerated, with Abbott acquiring a niche IVUS startup in late 2023 to bolster its peripheral catheter portfolio. Technological advancements include Terumoโs launch of a next-generation, high-resolution IVUS catheter with a smaller profile, addressing unmet needs in complex peripheral artery disease cases. Regulatory shifts, such as the FDAโs 2024 streamlined approval pathway for minimally invasive vascular devices, have spurred market entry of innovative solutions. Enterprise demand is also pivoting toward portable IVUS systems, driven by the rise of ambulatory surgical centers. Notably, a Series B funding round in early 2024 by a European IVUS startup underscored investor confidence in AI-integrated peripheral imaging technologies, signaling a long-term industry shift toward data-driven, precision-guided interventions.